BOCA RATON, Fla., March 7, 2024–(BUSINESS WIRE)–SurGenTec, a pioneering medical gadget firm specializing in orthopedic and spine applied sciences, proudly declares the primary implantations and 510(ok) clearance from the U.S. Food and Drug Administration (FDA) for its revolutionary OsteoFlo HydroPutty Artificial Bone Graft.
OsteoFlo HydroPutty represents a major development in bone graft know-how, that includes a mix of proprietary hydrophilic carriers designed to soak up fluids equivalent to bone marrow aspirate, blood or saline. This modern formulation turns to a putty and provides superior dealing with traits with a resorption profile optimized for bone development.
Travis Greenhalgh, Founder and Chief Govt Officer of SurGenTec, expressed enthusiasm about this milestone achievement: “We’re thrilled so as to add OsteoFlo HydroPutty to our portfolio. Its distinctive hydrophilic bonds allow the attachment of development components and supply a perfect scaffolding for bone development. This product underscores our dedication to creating next-generation options for physicians and sufferers.”
OsteoFlo HydroPutty is provided in a sterile vial as a dry formulation, accompanied by a mixing spatula. Upon the addition of fluid, the hydrophilic bonds swiftly take in the specified fluid to type a putty with superior dealing with traits. This versatile product might be packed into voids, resists irrigation, and should even be delivered seamlessly by way of the Graftgun® bone graft supply system.
Dr. Ashish Patel, MD, Chairman of Backbone Surgical procedure at Duly Health and Care, lauded OsteoFlo HydroPutty for its exceptional dealing with traits. “OsteoFlo HydroPutty, with its potential to soak up autologous blood merchandise and its ease of use, fills a important hole within the realm of artificial bone grafts. Its distinctive functionality to mix with allograft and move by way of small apertures makes it extraordinarily helpful when performing each open and minimally invasive surgical procedures.”
Echoing Dr. Patel’s sentiments, Dr. Tim O’Connor, M.D., Neurosurgeon and Director of Minimally Invasive and Robotic Backbone Surgical procedure at Baptist Health, emphasised the product’s versatility and ease. “OsteoFlo HydroPutty gives a transformative answer that includes development components like Bone Marrow Aspirate to reinforce fusion alternative. Most artificial putties are hydrophobic and repel fluid. HydroPutty differentiates itself by permitting me to ship subsequent era hydrophilic bone graft to maximise fusion in minimally invasive surgical procedure.”
OsteoFlo HydroPutty gives physicians with a completely artificial bone graft possibility, minimizing the dangers related to human tissue. By providing cutting-edge know-how whereas assuaging considerations equivalent to illness transmission and storage points, SurGenTec is empowering healthcare suppliers to ship optimum care to their sufferers. Brief-term and long-term pre-clinical research confirmed wonderful bone development and integration in any respect time factors.
SurGenTec, headquartered in Boca Raton, Florida, is devoted to creating and manufacturing modern merchandise for the orthopedic and neurosurgical spine fields. With a robust presence each domestically and internationally, SurGenTec is dedicated to optimizing fusion by way of its pipeline of artificial biologic product improvement.
For extra details about OsteoFlo HydroPutty and SurGenTec’s groundbreaking applied sciences, please go to www.SurGenTec.com.
About SurGenTec:
SurGenTec is a privately owned medical gadget firm based mostly in Boca Raton, Florida, specializing in distinctive applied sciences for orthopedic and spine remedies. With a give attention to next-generation synthetics to optimize therapeutic, SurGenTec is devoted to advancing affected person care worldwide.
Contacts
Media Contact:
customerservice@surgentec.com
Investor Contact:
Customerservice@surgentec.com
Discussion about this post